QUICK SEARCH:   [advanced] Author: Keyword(s):
Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Related articles in JCS Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Search for Related Content Social Bookmarking                         What's this?

Urokinase-type plasminogen activator: protease and mitogen

The proliferation of vascular smooth muscle cells (SMCs) is a key step in atherosclerosis and is accompanied by upregulation of the serine protease urokinase-type plasminogen activator (UPA). The proteolytic activity of UPA is important for tissue remodelling, but UPA also appears to function in signal transduction - for example, by binding to the receptor CD87. Since growth factors expressed during atherosclerosis promote UPA production, Joachim Kienast and co-workers have investigated whether UPA has a role in growth factor signalling (see p. 1961). The authors show that antibodies against endogenous UPA block stimulation of DNA synthesis and SMC proliferation by PDGF and basic FGF (bFGF). Interestingly, the effects of PDGF/bFGF do not depend on UPA-CD87 interaction but seem to require casein kinase 2 (CK2). The authors thus propose that stimulation of SMC proliferation by PDGF/bFGF involves a UPA/CK2-dependent, CD87-independent pathway. Given that the C-terminal (catalytic) domain of UPA is required both for the mitogenic effects and for any undesirable proteolysis, it might represent a good target for anti-atherogenesis therapies.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

Related articles in JCS:

The catalytic domain of endogenous urokinase-type plasminogen activator is required for the mitogenic activity of platelet-derived and basic fibroblast growth factors in human vascular smooth muscle cells

Teresa Padró, Rolf M. Mesters, Berno Dankbar, Heike Hintelmann, Ralf Bieker, Michael Kiehl, Wolfgang E. Berdel, and Joachim Kienast
JCS 2002 115: 1961-1971. [Abstract] [Full Text]  

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Related articles in JCS Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Search for Related Content Social Bookmarking                         What's this?